WO2023126249A1 - A sub-assembly of a medicament cassette unit - Google Patents
A sub-assembly of a medicament cassette unit Download PDFInfo
- Publication number
- WO2023126249A1 WO2023126249A1 PCT/EP2022/086956 EP2022086956W WO2023126249A1 WO 2023126249 A1 WO2023126249 A1 WO 2023126249A1 EP 2022086956 W EP2022086956 W EP 2022086956W WO 2023126249 A1 WO2023126249 A1 WO 2023126249A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- delivery member
- member cover
- sub
- housing
- longitudinal axis
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 121
- 210000002105 tongue Anatomy 0.000 description 10
- 206010039073 rheumatoid arthritis Diseases 0.000 description 7
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010009900 Colitis ulcerative Diseases 0.000 description 3
- 208000011231 Crohn disease Diseases 0.000 description 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 201000006704 Ulcerative Colitis Diseases 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 201000006417 multiple sclerosis Diseases 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 208000000592 Nasal Polyps Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 206010025135 lupus erythematosus Diseases 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 208000012260 Accidental injury Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 108010019673 Darbepoetin alfa Proteins 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 1
- 108010011459 Exenatide Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- DLSWIYLPEUIQAV-UHFFFAOYSA-N Semaglutide Chemical compound CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(O)=O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(C)(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O DLSWIYLPEUIQAV-UHFFFAOYSA-N 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 229960004539 alirocumab Drugs 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 229960003270 belimumab Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229960005029 darbepoetin alfa Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229950003468 dupilumab Drugs 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229950001616 erenumab Drugs 0.000 description 1
- 229960000403 etanercept Drugs 0.000 description 1
- 229960002027 evolocumab Drugs 0.000 description 1
- 229960001519 exenatide Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960004461 interferon beta-1a Drugs 0.000 description 1
- 108010027737 peginterferon beta-1a Proteins 0.000 description 1
- 229960001291 peginterferon beta-1a Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 229950006348 sarilumab Drugs 0.000 description 1
- 229960004540 secukinumab Drugs 0.000 description 1
- 229950011186 semaglutide Drugs 0.000 description 1
- 108010060325 semaglutide Proteins 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 description 1
- 229960003708 sumatriptan Drugs 0.000 description 1
- 229960003989 tocilizumab Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960004914 vedolizumab Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
- A61M2005/3267—Biased sleeves where the needle is uncovered by insertion of the needle into a patient's body
Definitions
- the present disclosure generally relates to a sub-assembly of a medicament cassette unit, and particularly to a sub-assembly comprises a housing, a delivery member cover, and a cap.
- Medicament delivery devices such as pen type manual injectors or auto-injectors are generally known for the self-administration of a medicament by patients without formal medical training.
- patients suffering from diabetes may require repeated injections of insulin, or patients may require regular injections of other types of medicaments, such as a growth hormone.
- the medicament delivery devices for the self-administration comprise automatic functions so that even if users are without professional training or are in an emergency situation, the users can easily and properly use the medicament delivery devices.
- distal direction refers to the direction pointing away from the dose delivery site during use of the medicament delivery device.
- distal part/end refers to the part/end of the delivery device, or the parts/ends of the members thereof, which under use of the medicament delivery device is/are located furthest away from the dose delivery site.
- proximal direction refers to the direction pointing towards the dose delivery site during use of the medicament delivery device.
- proximal part/end this refers to the part/end of the delivery device, or the parts/ends of the members thereof, which under use of the medicament delivery device is/are located closest to the dose delivery site.
- longitudinal refers to a direction extending from the proximal end to the distal end, typically along the device or components thereof in the direction of the longest extension of the device and/or component.
- transverse refers to a direction generally perpendicular to the longitudinal direction.
- circumference refers to a circumference or a circumferential direction relative to an axis, typically a central axis extending in the direction of the longest extension of the device and/or component.
- radial refers to a direction extending radially relative to the axis
- rotation refers to rotation relative to the axis.
- a sub-assembly of a medicament cassette unit comprising: a tubular housing, a delivery member cover, and a cap; the tubular housing extends along a longitudinal axis between a proximal end and a distal end; the tubular housing is configured to receive a medicament container; the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; the delivery member cover comprises a distally directed surface; the cap is releasably attached to the tubular section of the delivery member cover; the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover; at least one of the distally directed surface and the proximally directed surface is a chamfer surface bevelled relative to the longitudinal axis; the distally directed surface is formed on a protrusion that extends from a flexible wall of the delivery member cover in a direction transverse to the longitudinal axis or
- the flexible wall is defined by a flexible arm extending in the direction of the longitudinal axis.
- the cap comprises the flexible arm extending towards the distal end of the housing.
- the distally directed surface of the delivery member cover extends from an outer surface of the tubular section of the delivery member cover.
- the sub-assembly comprising a biasing member extending along the longitudinal axis between a proximal end and a distal end; and the distal end of the biasing member is adjacent to a proximally directed surface of the tubular housing and the proximal end of the biasing member is adjacent to a distally directed surface of the delivery member cover.
- the delivery member cover comprises a ledge extending in the direction transverse to the longitudinal axis; and wherein the distally directed surface of the delivery member cover is defined by the ledge.
- the cap comprises a gripping arm extending towards the distal end of the tubular housing; the gripping arm comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
- the gripping arm of the cap is arranged within the delivery member cover; and the flexible wall of the cap is arranged between the tubular housing and the delivery member cover.
- the delivery member cover comprises a flexible section at a distal end of the delivery member cover; and wherein the flexible section comprises a protrusion extending from the delivery member cover towards the tubular housing in the direction transverse to the longitudinal axis.
- a cut-out or recess is arranged in a wall of the tubular housing; and the flexible section is movable in the direction transverse to the longitudinal axis relative to the delivery member cover between an engaged position where the protrusion of the flexible section is positioned within the cut-out or recess of the tubular housing and a released position where the protrusion of the flexible section is positioned out of the cut-out or recess of the tubular housing.
- the flexible section of the delivery member cover is moved from the engaged position where the protrusion of the flexible section is positioned within the cut-out to the released position where the protrusion of the flexible section is positioned out of the cut-out when the protrusion of the flexible section is pressed from the outside of the tubular housing.
- the flexible section of the delivery member cover is configured to be moved from the engaged position to the released position by a section of a drive unit of the medicament delivery device when the cassette unit with the subassembly is attached to the drive unit.
- the flexible section is moved by the drive unit via the protrusion.
- the protrusion is configured to extend out from the housing through the cut-out of the housing.
- a method of operating a medicament delivery device comprises the following steps in the following order: providing a medicament cassette unit of the medicament delivery device, wherein the medicament cassette unit comprises the sub-assembly of the invention; providing a drive unit of the medicament delivery device, wherein the drive unit comprises a section for receiving a part of the medicament cassette unit; inserting the part of the medicament cassette unit into the section of the drive unit, thereby engaging the flexible section of the delivery member cover of the medicament cassette unit with an inner surface of the drive unit; moving the delivery member cover from the distal position to the proximal position; and pulling the cap in the proximal direction relative to the tubular housing, thereby removing the cap from the tubular housing.
- the sub-assembly is used in a medicament delivery device comprising a multiple-chamber medicament container arranged within the carrier.
- the medicament delivery device is an injection device, an inhalation device, or a medical sprayer.
- the medicament delivery device is an autoinjector.
- the medicament delivery member is an injection needle or a spray nozzle.
- the medicament container is a syringe or a cartridge.
- the medicament delivery devices described herein can be used for the treatment and/or prophylaxis of one or more of many different types of disorders.
- exemplary disorders include, but are not limited to: rheumatoid arthritis, inflammatory bowel diseases (e.g.
- exemplary drugs that could be included in the medicament delivery devices described herein include, but are not limited to (with non-limiting examples of relevant disorders in brackets): etanercept (rheumatoid arthritis, inflammatory bowel diseases (e.g.
- evolocumab hypercholesterolaemia
- exenatide type 2 diabetes
- secukinumab psoriasis
- erenumab mimerase
- alirocumab rheumatoid arthritis
- methotrexate amethopterin
- tocilizumab rheumatoid arthritis
- interferon beta-1 a multiple sclerosis
- sumatriptan miraines
- adalimumab rheumatoid arthritis
- darbepoetin alfa anaemia
- belimumab laupus
- peginterferon beta-1 a' multiple sclerosis
- sarilumab rheumatoid arthritis
- semaglutide type 2 diabetes, obesity
- dupilumab atopic dermatis, asthma, nasal polyps, allergies
- glucagon glucagon
- compositions including, but not limited to, any drug described herein are also contemplated for use in the medicament delivery devices described herein, for example pharmaceutical formulations comprising a drug as listed herein (or a pharmaceutically acceptable salt of the medicament) and a pharmaceutically acceptable carrier.
- Pharmaceutical formulations comprising a drug as listed herein (or a pharmaceutically acceptable salt of the medicament) may include one or more other active ingredients, or may be the only active ingredient present.
- Fig. 1 schematically shows a perspective view of a medicament cassette unit comprising a sub-assembly of the invention.
- Fig. 2 schematically shows a medicament delivery device formed by a drive unit and the medicament cassette unit of Fig. 1 .
- Fig. 3 schematically shows a perspective view of components of the sub-assembly of Fig. 1 .
- Fig. 4 schematically shows a perspective view of a housing and a delivery member cover of the sub-assembly of Fig. 1 .
- Fig. 5 schematically shows a perspective view of a rear end of the housing and the delivery member cover of Fig. 4.
- Fig. 6 schematically shows a perspective view of a cap of the sub-assembly of the invention of Fig. 1 .
- Fig. 7 schematically shows a perspective view of the cap of Fig. 6 and a proximal end of the delivery member cover of Fig. 4.
- Fig. 8 schematically shows a perspective view of the housing of Fig. 4.
- Figs 9-10 schematically show cross-section views of a proximal end of the sub-assembly.
- Figs 11-12 schematically show perspective views of a lockout structure between the delivery member cover of the sub-assembly of Fig. 1 and the housing of the sub-assembly of Fig. 1 .
- Figs 13-16 schematically show perspective views of a proximal end of the sub-assembly in another example.
- Fig. 17 schematically shows a perspective view of a lock ring of the sub-assembly in another example and the delivery member cover of the sub-assembly in another example.
- Figs 1-17 illustrate a sub-assembly of a medicament cassette unit.
- the term “medicament delivery device cassette unit” will sometimes be abbreviated as “cassette unit” in this description. It should be noted that both the term “medicament delivery device cassette unit” and the term “cassette unit” are used with the same meaning in this description.
- the cassette unit is usually used with a medicament delivery device with two detachable parts, as shown in Fig. 2.
- a medicament delivery device with two detachable parts
- There can be certain technical demands for making a medicament delivery device such as a controllable medicament delivery speed; a high output force to deliver a high volume and/or high viscosity medicament; multiple indications for different medicament delivery stages; and/or data recording and/or communication, for example, to track prescription adherence.
- the cost of manufacturing medicament delivery devices that can perform all functions and fulfil the technical demands described above is typically high, which makes the use of such medicament delivery devices for frequent treatments less affordable.
- Medicament delivery devices with two detachable parts are usually made with a reusable part and a disposable part. The reusable part comprises most of the mechanical and/or electronic components.
- the reusable part normally comprises a powerpack, namely, an assembly that comprises a power source and components that are configured to transfer the output force from the power source to a medicament.
- the disposable part is usually without electronics to lower the cost of manufacture.
- the disposable part commonly referred to as a cassette unit C, is usually designed to accommodate a medicament container, e.g. a syringe or cartridge, that has a medicament contained within.
- the syringe or cartridge can be made of glass or plastic.
- the syringe or cartridge may comprise a rubber stopper sealing a distal end of the syringe or cartridge, and a septum or medicament delivery member with a rubber sheath sealing a proximal end of the syringe or cartridge.
- the syringe or cartridge may be collapsible with only a septum or medicament delivery member (i.e. no stopper) with a rubber delivery member sheath sealing a proximal end of the syringe or cartridge.
- a septum or medicament delivery member i.e. no stopper
- a rubber delivery member sheath sealing a proximal end of the syringe or cartridge.
- the septum or the rubber sheath usually provides a sterile seal for the medicament container of the cassette unit. The sterile seal is configured to be broken right when a user wants to carry out a medicament delivery operation.
- the reusable part of the medicament delivery device usually comprises a driver for expelling the medicament contained within the medicament container in the proximal direction of the medicament delivery device.
- the drive unit D may comprise a plunger rod for pushing on the medicament container.
- the stopper of the medicament container can therefore be moved in the proximal direction relative to the rest of the medicament container.
- the plunger rod may collapse the medicament container by pushing the medicament container in the proximal direction relative to the cassette unit C.
- the drive unit D also comprises a power source, such as a spring, a gas canister, or a motor-driven gear set, for providing the power required to expel the medicament.
- the sub-assembly of the invention provides a safety mechanism configured to prevent the user from breaking the sterile seal of the medicament container of the cassette unit before attaching the cassette unit to the drive unit.
- the sub-assembly also provides a mechanism that a delivery member cover is moved in a proximal direction relative to the tubular body when the cassette unit is attached to the drive unit D (the cassette unit comprises the subassembly of the invention). The proximal movement of the delivery member cover is configured to unlock the safety mechanism.
- the sub-assembly comprises a tubular housing 1 ; T, a cap 2; 2’, and a delivery member cover 3; 3’.
- the tubular housing 1 ; T extends along a longitudinal axis L between a proximal end and a distal end.
- the tubular housing 1 ; T is configured to receive the medicament container of the cassette unit.
- the tubular housing 1 ; T comprises a housing body 10; 10’ and a distal lid 13.
- the medicament container is configured to be inserted into the housing body 10 through the distal end of the housing body 10.
- the step of inserting the medicament container into the housing body 10 can be carried out during the assembly step in a medicament delivery device manufacture site, or by a caregiver, e.g., a pharmacist or a nurse.
- the distal lid 13 is configured to attach to the distal end of the housing body 10, so that the medicament container will not fall from the distal end of the housing 1 .
- An aperture is arranged in the distal lid 13, so that a plunger rod from the drive unit can move into the housing 1 for expelling the medicament within the medicament container.
- the tubular housing 1 comprises a fastener 11 configured to engage with a counter fastener DO of the drive unit D, so that the cassette unit is attached to the drive unit.
- the fastener 11 is on the distal end of the housing 1 .
- the fastener 11 and the counter fastener DO can form a bayonet engagement, a screw thread engagement, or a snap-fit engagement, dependent on the design of the medicament delivery device, as shown in Fig. 2.
- the sub-assembly comprises a lock ring 5 attached to the housing 1’.
- the lock ring 5 is axially immovable and rotatable around the longitudinal axis L relative to the housing T.
- the lock ring 5 comprises a fastener 51 configured to be engaged with the counter fastener DO of the drive unit, as shown in Fig. 17.
- the fastener 51 and the counter fastener DO formed a bayonet connection.
- a window 12 is arranged in the wall of the housing body 10, so that the user can observe the medicament through the window 12.
- the delivery member cover 3; 3’ comprises a tubular section 30; 30’ is arranged telescopically relative to the proximal end of the housing 1 ; T.
- the tubular section 30; 30’ of the delivery member cover 3; 3’ is configured to cover the medicament delivery member of the cassette unit, e.g., an injection needle.
- the delivery member cover 3; 3’ comprises an arm 31 ; 3T extending from the tubular section 30; 30’ towards the distal end of the housing 1 ; T.
- the delivery member cover 3 comprises a flexible section 32 at a distal end of the delivery member cover 3.
- the flexible section is a part of the arm or is extending from the arm 31 .
- the flexible section comprises a protrusion 32 extending from the delivery member cover 3 towards the tubular housing 1 in the direction transverse to the longitudinal axis L, as shown in Fig. 4.
- the delivery member cover 3 comprises a lockout structure 33, as shown in Fig. 4 and Fig. 11 .
- the delivery member cover 3 is configured to be moved in the distal direction by the user such that the medicament delivery member of the cassette unit is exposed and thus the medicament delivery operation can be carried out.
- the user can lift the delivery member cover 3 from a medicament delivery site, the delivery member cover 3 can move in the proximal direction relative to the housing 1 to cover the medicament delivery member again.
- the lockout structure 33 is configured to block the delivery member cover 3 from moving in the distal direction relative to the housing 1 after the user lift the delivery member cover 3 from the medicament delivery site so that the used medicament delivery member will be covered and prevented from being accessible from the outside of the medicament delivery device, as shown in Fig. 12.
- the lockout structure 33 comprises a track 33a and the housing 1 comprises a track follower 15, e.g., a protrusion, configured to move along the track.
- a locking ton gue 33b extends from a portion of the track 33a that the track follow can move into that portion after the delivery member cover 3 covers the medicament delivery member again.
- the delivery member cover 3 is configured to be moved to cover the medicament delivery member by a biasing member 4.
- the locking tongue 33b can be designed to be bent and disengaged from the track follower 15 of the housing when the force that applies to the delivery member cover 3 in the distal direction is greater than a predetermined magnitude. Therefore, the locking tongue 33b can be prevented from being damaged by being squeezed between the delivery member cover 3 and the track follower 15. After the force applies to the delivery member cover 3 in the distal direction is removed or becomes weaker than the force from the biasing member 4, the biasing member will move the delivery member cover 3 back to the position that the delivery member is covered and the locking tongue 3b will engage the track follower 15 again to lock the delivery member cover 3 from being moved in the distal position.
- This design is configured to prevent a damage to the lockout structure; in particular, when the used medicament delivery device falls.
- the locking tongue 33b comprises a lever 33c configured to guide the locking tongue to disengaged from the track follower 15.
- the locking tongue 33b comprises a distally directed surface 33d configured to engage with the track follower 15 of the housing.
- the lever 33c extends beyond the distally directed surface 33d of the locking tongue 33b, as shown in Fig. 11 .
- the track follower 15 is configured to press the lever 33c in the direction transverse to the longitudinal axis L, and towards the longitudinal axis when the track follower 15 is engaged with the distally directed surface 33d of the locking tongue 33b. Therefore, when the force that applies to the delivery member cover 3 in the distal direction is greater than the predetermined magnitude and the distally directed surface 33d is engaged with the track follower 15, the lever will be pressed further towards the longitudinal axis L and thus pulls the locking tongue towards the longitudinal axis L to disengage from the track follower 15.
- the cap 2; 2’ is releasably attached to the tubular section 30; 30’ of the delivery member cover 3; 3’.
- the cap 2; 2’ operably connects to the sterile seal of the medicament container of the cassette unit, so that when the cap 2; 2’ is removed the sterile seal of the medicament container of the cassette unit is broken.
- the cap 2; 2’ comprises a user-accessible section 20; 20’, so that the user can grip on the user-accessible section 20; 20’ to remove the cap 2; 2’ from the delivery member cover 3; 3’.
- the cap 2 comprises a gripping arm 22 extending towards the distal end of the tubular housing 1 .
- the gripping arm 22 comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
- the delivery member cover 3; 3’ is configured to lock the cap 2; 2’ to the housing 1 ; T.
- the delivery member cover 3; 3’ is movable between a first position where the cap 2; 2’ is locked to the housing 1 ; 1 ’ by the delivery member cover 3; 3’ such that the user cannot remove the cap 2; 2’ from the housing 1 ; T and a second position where the cap 2; 2’ is no longer locked to the housing 1 ; 1 ’ by the delivery member cover 3; 3’.
- the delivery member cover 3; 3’ comprises a the distally directed surface 31a; 31a’ and the cap 2; 2’ comprises a proximally directed surface 21 a; 21 a’.
- the distally directed surface 31a; 31a’ of the delivery member cover 3; 3’ is adjacent to the proximally directed surface 21a; 21a’ of the cap 2; 2’, as shown in Fig. 9 and Fig. 16.
- the distally directed surface 31 a; 31 a’ of the delivery member cover 3; 3’ is away from the proximally directed surface 21a; 21a’ of the cap 2; 2’ such that the cap 2; 2’ can be removed from the delivery member cover 3; 3’ by being moved in the proximal direction relative to the delivery member cover 3; 3’, as shown in Fig. 10.
- the delivery member cover 3 is movable in the direction of the longitudinal axis L relative to the housing 1 between a distal position (shown in Fig. 9) and a proximal position (shown in Fig. 10).
- the safety mechanism is provided that the cap 2 cannot be detached from the tubular section 30 of the delivery member cover 3 when the delivery member cover 3 is in the distal position such that the delivery member cover is in the first position, and can be detached from the tubular section 30 of the delivery member cover 3 when the delivery member cover moves a distance X into the in the proximal direction relative to the housing 1 into the proximal position such that the delivery member cover is moved to the second position.
- the delivery member cover comprises the distally directed surface 31a and the cap comprises the proximally directed surface 21a adjacent to the distally directed surface 31a of the delivery member cover 3.
- At least one of the distally directed surface and the proximally directed surface is a chamfered surface bevelled relative to the longitudinal axis L.
- the proximally directed surface 21 a is a chamfered surface bevelled relative to the longitudinal axis L.
- the bevelled angle can be 30- 70 degrees, more preferred angle can be 40-60 degrees.
- the proximally directed surface 21 a is formed on a protrusion that extends from an inner surface of a flexible wall 21 of the cap 2 in the direction transverse to the longitudinal axis L.
- the distally directed surface can be formed on a protrusion that extends from a flexible wall of the delivery member cover.
- the flexible wall 21 of the cap 2 is a flexible arm 21 extending from the user-accessible section in the direction of the longitudinal axis L towards the distal end of the housing 1.
- the protrusion is arranged at the distal end of the flexible arm 21 .
- the gripping arm 22 of the cap 2 is arranged within the delivery member cover 3, and the flexible arm 21 of the cap 2 is arranged between the tubular housing 1 and the delivery member cover 3, as shown in Figs 9-10.
- the housing 1 comprises a support surface 10a defined by an inner surface of a wall of the housing body 10.
- the support surface 10a is closer to the proximal end of the housing 1 than the distal end of the housing 1 .
- the support surface 10a is arranged next to a proximal inner surface 10b of the housing body 10.
- the support surface 10a is closer to the distal end of the housing 1 than the proximal inner surface 10b.
- the support surface 10a is closer to the longitudinal axis than the proximal inner surface 10b of the housing body 10 as shown in Figs 8-10.
- the housing 1 comprises two support surfaces 10a and two proximal inner surfaces 10b.
- the two support surfaces 10a defines a first transverse distance.
- the first transverse distance is shorter than a second transverse distance between the two proximal inner surfaces 10b.
- the cap 2 is engaged with the delivery member cover 3 via the engagement between the proximally directed surface 21 a and the distally directed surface 31 a, so that the cap 2 moves with the delivery member cover 3 from the distal position to the proximal position.
- the support surface 10a of the tubular housing 1 is aligned with an outer surface of the flexible wall 21 in the direction transverse to the longitudinal axis L, as shown in Fig. 9.
- the support surface 10a of the tubular housing 1 is closer to the distal end of the housing 1 than the flexible wall 21 , as shown in Fig. 10.
- the flexible wall 21 is blocked from moving in the direction transverse to the longitudinal axis L by the support surface 10a, and when the delivery member cover 3 is in the proximal position, the flexible wall 21 is no longer blocked from moving in the direction transverse to the longitudinal axis L by the support surface 10a. Therefore, if the user pulls the cap 2 in the proximal position when the delivery member cover 3, the bevelled proximally directed surface 21 will divide the axial pulling force to deflect the flexible wall 21 , thereby moving the flexible wall in the direction transverse to the longitudinal axis L.
- the proximally directed surface 21a of the cap 2 is offset from the distally directed surface 31a of the delivery member cover 3, so that the cap 2 can be removed from the delivery member cover 3 as the proximally directed surface 21 a of the cap 2 is no longer engaged with the distally directed surface 31a of the delivery member cover 3.
- the proximal inner surface 10b of the housing 1 is dimensioned wider enough to allow the proximally directed surface 21 of the cap 2 can disengage with the distally directed surface 31a of the delivery member cover 3.
- the exact dimension is of the proximal inner surface 10b of the housing 1 is dependent on the design.
- an elongated cut-out can be arranged in the proximal end of the housing body. The elongated cut-out is arranged next to the support surface and is close to the proximal end of the housing than the support surface.
- the sub-assembly comprises the biasing member 4 extending along the longitudinal axis L between a proximal end and a distal end.
- the distal end of the biasing member 4 is adjacent to a proximally directed surface of the tubular housing 1 and the proximal end of the biasing member 4 is adjacent to a distally directed surface of the delivery member cover 3.
- the biasing member 4 is configured to move the delivery member cover 3 from the distal position to the proximal position.
- the sub-assembly comprises an initial lock mechanism, so that the delivery member cover 3 is locked from moving to the proximal position until the cassette unit that comprises the sub-assembly is attached to the drive unit D.
- the initial lock arrangement comprises the flexible section at the distal end of the delivery member cover 3.
- a cut-out 14 is arranged in a wall of the tubular housing 1 .
- the flexible section is movable in the direction transverse to the longitudinal axis L relative to the delivery member cover 3 between an engaged position where the protrusion 32 of the flexible section is positioned within the cut-out 14 of the tubular housing 1 and a released position where the protrusion 32 of the flexible section is positioned out of the cut-out 14 the tubular housing 1 .
- the cut-out can be replaced by a recess.
- the flexible section of the delivery member cover 3 is moved from the engaged position to the released position when the protrusion 32 of the flexible section is pressed from the outside of the tubular housing 1 .
- the flexible section of the delivery member cover 3 is configured to be moved from the engaged position to the released position by a section of the drive unit D of the medicament delivery device when the cassette unit with the sub-assembly is attached to the drive unit.
- the flexible section is moved by the drive unit via the protrusion 32.
- the protrusion 32 is configured to extend out from the housing 1 through the cut-out 14 of the housing 1 , as shown in Fig. 5.
- the section of the drive unit D e.g. an inner surface of the drive unit moves the protrusion 32 in the direction transverse to the longitudinal axis L, thereby deforming the flexible section.
- the deformation of the flexible section causes the protrusion 32 to move out from the cut-out 14 of the housing 1 , so that the housing 1 is not locked to the delivery member cover 3.
- the delivery member cover 3 is moved from the distal position to the proximal position by the biasing member 4.
- the delivery member cover 3’ is configured to be rotated around the longitudinal axis L relative to the housing T from the first position to the second position.
- the distally directed surface 31 a’ of the delivery member cover 3’ can be provided by a ledge 3T arranged on an inner surface of the tubular section 30’, as shown in Figs. 14-15.
- a groove 31 b’ is arranged in the ledge 3T, as shown in Fig. 14.
- the proximally directed surface 21 a’ of the cap 2’ can be arranged at an elongated rib 2T of the cap 2’.
- the distally directed surface 31 a’ of the delivery member cover 3’ is adjacent to the proximally directed surface 21 a’ of the cap 2’; therefore, the cap 2’ cannot be removed from the housing 1 ’.
- the distally directed surface 31 a’ of the delivery member cover 3’ is no longer adjacent to the proximally directed surface 21 a’ of the cap 2’; instead, the the proximally directed surface 21 a’ of the cap 2’ is lined up with the groove 31 b’; therefore, the cap 2’ can be removed from the housing 1 ’ by being moved in the proximal direction relative to the housing T and the delivery member cover 3’.
- a proximally directed recess 16’ is arranged in a wall of the housing T, as shown in Fig. 16.
- One end of the elongated rib 2T of the cap 2’ is positioned within the recess 16’ such that the cap 2’ cannot be rotated relative to the housing 1 ’.
- the lock ring 5 comprises a rotational surface 52 facing in the direction transverse to the longitudinal axis L.
- the delivery member cover 3’ comprises a counter rotational surface adjacent to the rotational surface 52 of the lock ring 5 such that the delivery member cover is configured to be rotated from the first position to the second position by a rotation of the lock ring 5, as shown in Fig. 17.
- the counter rotational surface of the delivery member cover 3’ is a transverse edge of the arm 3T of the delivery member cover 3’.
- the lock ring 5 comprises the fastener 51 configured to be engaged with a counter fasten er DO of the drive unit and the fastener 51 and the counter fastener DO formed a bayonet connection, as the lock ring is rotatable relative to the housing T, when the user twist the housing T relative to the drive unit for connecting the cassette unit to the drive unit via the bayonet connection, the lock ring 5 rotates the delivery member cover 3’ from the first position to the second position.
- a sub-assembly of a medicament cassette unit comprising: a tubular housing, a cap, and a delivery member cover; wherein the tubular housing extends along a longitudinal axis between a proximal end and a distal end; wherein the tubular housing is configured to receive a medicament container; wherein the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; wherein the delivery member cover comprises a distally directed surface; wherein the cap is releasably attached to the tubular section of the delivery member cover; wherein the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover; wherein at least one of the distally directed surface and the proximally directed surface is a chamfered surface bevelled relative to the longitudinal axis; wherein the distally directed surface is formed on a protrusion that extends from an inner surface of a flexible
- the sub-assembly comprising a biasing member extending along the longitudinal axis between a proximal end and a distal end; and wherein the distal end of the biasing member is adjacent to a proximally directed surface of the tubular housing and the proximal end of the biasing member is adjacent to a distally directed surface of the delivery member cover.
- the delivery member cover comprises a ledge extending in the direction transverse to the longitudinal axis; and wherein the distally directed surface of the delivery member cover is defined by the ledge.
- the cap comprises a gripping arm extending towards the distal end of the tubular housing; wherein the gripping arm comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
- the delivery member cover comprises a flexible section at a distal end of the delivery member cover; and wherein the flexible section comprises a protrusion extending from the delivery member cover towards the tubular housing in the direction transverse to the longitudinal axis.
- a method of operating a medicament delivery device comprising the following steps in the following order: providing a medicament cassette unit of the medicament delivery device, wherein the medicament cassette unit comprises the sub-assembly according to clause 14; providing a drive unit of the medicament delivery device, wherein the drive unit comprises a section for receiving a part of the medicament cassette unit; inserting the part of the medicament cassette unit into the section of the drive unit, thereby engaging the flexible section of the delivery member cover of the medicament cassette unit with an inner surface of the drive unit; moving the delivery member cover from the distal position to the proximal position; and pulling the cap in the proximal direction relative to the tubular housing, thereby removing the cap from the tubular housing.
- a sub-assembly of a medicament cassette unit comprising: a tubular housing, a cap, and a delivery member cover; wherein the tubular housing extends along a longitudinal axis between a proximal end and a distal end; wherein the tubular housing is configured to receive a medicament container; wherein the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; wherein the delivery member cover comprises a distally directed surface; wherein the cap is releasably attached to the tubular section of the delivery member cover; wherein the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover; and wherein the delivery member cover is movable between a first position where the distally directed surface of the delivery member cover is adjacent to the proximally directed surface of the cap and a second position where the distally directed surface of the delivery member cover is away from the proximally directed surface
- sub-assembly according to any one of clauses 16-20, the sub-assembly comprising a biasing member extending along the longitudinal axis between a proximal end and a distal end; and wherein the distal end of the biasing member is adjacent to a proximally directed surface of the tubular housing and the proximal end of the biasing member is adjacent to a distally directed surface of the delivery member cover.
- the cap comprises a gripping arm extending towards the distal end of the tubular housing; wherein the gripping arm comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
- the sub-assembly according to any one of clauses 26-29, wherein the protrusion is configured to extend out from the housing through the cut-out of the housing.
- the lock ring comprises a fastener configured to be engaged with a counter fastener of the drive unit; and wherein the fastener and the counter fastener formed a bayonet connection.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Environmental & Geological Engineering (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A sub-assembly of a medicament cassette unit, the sub-assembly comprising: a tubular housing, a delivery member cover, and a cap; the tubular housing extends along a longitudinal axis between a proximal end and a distal end; the tubular housing is configured to receive a medicament container; the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; the delivery member cover comprises a distally directed surface; the cap is releasably attached to the tubular section of the delivery member cover; the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover.
Description
TITLE
A sub-assembly of a medicament cassette unit
TECHNICAL FIELD
The present disclosure generally relates to a sub-assembly of a medicament cassette unit, and particularly to a sub-assembly comprises a housing, a delivery member cover, and a cap.
BACKGROUND
Medicament delivery devices such as pen type manual injectors or auto-injectors are generally known for the self-administration of a medicament by patients without formal medical training. For example, patients suffering from diabetes may require repeated injections of insulin, or patients may require regular injections of other types of medicaments, such as a growth hormone.
It is an advantage when the medicament delivery devices for the self-administration comprise automatic functions so that even if users are without professional training or are in an emergency situation, the users can easily and properly use the medicament delivery devices.
Even though many of the devices on the market, as well as the ones described above, have their respective advantages, there is still room for improvements.
SUMMARY
The invention is defined by the appended claims, to which reference should now be made.
In the present disclosure, when the term “distal direction” is used, this refers to the direction pointing away from the dose delivery site during use of the medicament delivery device. When the term “distal part/end” is used, this refers to the part/end of the delivery device, or the parts/ends of the members thereof, which under use of the medicament delivery device is/are located furthest away from the dose delivery site. Correspondingly, when the term “proximal direction” is used, this refers to the direction pointing towards the dose delivery site during use of the medicament delivery device. When the term “proximal part/end” is used, this refers to the part/end of the delivery device, or the parts/ends of the members thereof, which under use of the medicament delivery device is/are located closest to the dose delivery site.
Further, the term “longitudinal”, “longitudinally”, “axially” or “axial” refer to a direction extending from the proximal end to the distal end, typically along the device or components thereof in the direction of the longest extension of the device and/or component.
Similarly, the terms “transverse”, “transversal” and “transversally” refer to a direction generally perpendicular to the longitudinal direction.
Further, the terms “circumference”, “circumferential”, or “circumferentially” refer to a circumference or a circumferential direction relative to an axis, typically a central axis extending in the direction of the longest extension of the device and/or component. Similarly, “radial” or “radially” refer to a direction extending radially relative to the axis, and “rotation”, “rotational” and “rotationally” refer to rotation relative to the axis.
There is hence provided a sub-assembly of a medicament cassette unit, the sub-assembly comprising: a tubular housing, a delivery member cover, and a cap; the tubular housing extends along a longitudinal axis between a proximal end and a distal end; the tubular housing is configured to receive a medicament container; the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; the delivery member cover comprises a distally directed surface; the cap is releasably attached to the tubular section of the delivery member cover; the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover; at least one of the distally directed surface and the proximally directed surface is a chamfer surface bevelled relative to the longitudinal axis; the distally directed surface is formed on a protrusion that extends from a flexible wall of the delivery member cover in a direction transverse to the longitudinal axis or the proximally directed surface is formed on a protrusion that extends from a flexible wall of the cap in the direction transverse to the longitudinal axis; and the delivery member cover is axially movable relative to the tubular housing from a distal position where a support surface of the tubular housing is aligned with an outer surface of the flexible wall in the direction transverse to the longitudinal axis and a proximal position where the support surface of the tubular housing is closer to the distal end of the housing than the flexible wall.
Preferably, according to another embodiment, the flexible wall is defined by a flexible arm extending in the direction of the longitudinal axis.
Preferably, according to another embodiment, the cap comprises the flexible arm extending towards the distal end of the housing.
Preferably, according to another embodiment, the distally directed surface of the delivery member cover extends from an outer surface of the tubular section of the delivery member cover.
Preferably, according to another embodiment, the sub-assembly comprising a biasing member extending along the longitudinal axis between a proximal end and a distal end; and the distal end of the biasing member is adjacent to a proximally directed surface of the
tubular housing and the proximal end of the biasing member is adjacent to a distally directed surface of the delivery member cover.
Preferably, according to another embodiment, the delivery member cover comprises a ledge extending in the direction transverse to the longitudinal axis; and wherein the distally directed surface of the delivery member cover is defined by the ledge.
Preferably, according to another embodiment, the cap comprises a gripping arm extending towards the distal end of the tubular housing; the gripping arm comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
Preferably, according to another embodiment, the gripping arm of the cap is arranged within the delivery member cover; and the flexible wall of the cap is arranged between the tubular housing and the delivery member cover.
Preferably, according to another embodiment, the delivery member cover comprises a flexible section at a distal end of the delivery member cover; and wherein the flexible section comprises a protrusion extending from the delivery member cover towards the tubular housing in the direction transverse to the longitudinal axis.
Preferably, according to another embodiment, a cut-out or recess is arranged in a wall of the tubular housing; and the flexible section is movable in the direction transverse to the longitudinal axis relative to the delivery member cover between an engaged position where the protrusion of the flexible section is positioned within the cut-out or recess of the tubular housing and a released position where the protrusion of the flexible section is positioned out of the cut-out or recess of the tubular housing.
Preferably, according to another embodiment, the flexible section of the delivery member cover is moved from the engaged position where the protrusion of the flexible section is positioned within the cut-out to the released position where the protrusion of the flexible section is positioned out of the cut-out when the protrusion of the flexible section is pressed from the outside of the tubular housing.
Preferably, according to another embodiment, the flexible section of the delivery member cover is configured to be moved from the engaged position to the released position by a section of a drive unit of the medicament delivery device when the cassette unit with the subassembly is attached to the drive unit.
Preferably, according to another embodiment, the flexible section is moved by the drive unit via the protrusion.
Preferably, according to another embodiment, the protrusion is configured to extend out from the housing through the cut-out of the housing.
In another aspect of the invention, a method of operating a medicament delivery device is provided. The method comprises the following steps in the following order: providing a medicament cassette unit of the medicament delivery device, wherein the medicament cassette unit comprises the sub-assembly of the invention; providing a drive unit of the medicament delivery device, wherein the drive unit comprises a section for receiving a part of the medicament cassette unit; inserting the part of the medicament cassette unit into the section of the drive unit, thereby engaging the flexible section of the delivery member cover of the medicament cassette unit with an inner surface of the drive unit; moving the delivery member cover from the distal position to the proximal position; and pulling the cap in the proximal direction relative to the tubular housing, thereby removing the cap from the tubular housing.
Preferably, according to another embodiment, the sub-assembly is used in a medicament delivery device comprising a multiple-chamber medicament container arranged within the carrier.
Preferably, according to another embodiment, the medicament delivery device is an injection device, an inhalation device, or a medical sprayer.
Preferably, according to another embodiment, the medicament delivery device is an autoinjector.
Preferably, according to another embodiment, the medicament delivery member is an injection needle or a spray nozzle.
Preferably, according to another embodiment, the medicament container is a syringe or a cartridge.
Generally, the medicament delivery devices described herein can be used for the treatment and/or prophylaxis of one or more of many different types of disorders. Exemplary disorders include, but are not limited to: rheumatoid arthritis, inflammatory bowel diseases (e.g.
Crohn’s disease and ulcerative colitis), hypercholesterolaemia, diabetes (e.g. type 2 diabetes), psoriasis, migraines, multiple sclerosis, anaemia, lupus, atopic dermatitis, asthma, nasal polyps, acute hypoglycaemia, obesity, anaphylaxis and allergies. Exemplary drugs that could be included in the medicament delivery devices described herein include, but are not limited to (with non-limiting examples of relevant disorders in brackets): etanercept (rheumatoid arthritis, inflammatory bowel diseases (e.g. Crohn’s disease and ulcerative colitis)), evolocumab (hypercholesterolaemia), exenatide (type 2 diabetes), secukinumab
(psoriasis), erenumab (migraines), alirocumab (rheumatoid arthritis), methotrexate (amethopterin) (rheumatoid arthritis), tocilizumab (rheumatoid arthritis), interferon beta-1 a (multiple sclerosis), sumatriptan (migraines), adalimumab (rheumatoid arthritis), darbepoetin alfa (anaemia), belimumab (lupus), peginterferon beta-1 a' (multiple sclerosis), sarilumab (rheumatoid arthritis), semaglutide (type 2 diabetes, obesity), dupilumab (atopic dermatis, asthma, nasal polyps, allergies), glucagon (acute hypoglycaemia), epinephrine (anaphylaxis), insulin (diabetes), atropine and vedolizumab (inflammatory bowel diseases (e.g. Crohn’s disease and ulcerative colitis)). Pharmaceutical formulations including, but not limited to, any drug described herein are also contemplated for use in the medicament delivery devices described herein, for example pharmaceutical formulations comprising a drug as listed herein (or a pharmaceutically acceptable salt of the medicament) and a pharmaceutically acceptable carrier. Pharmaceutical formulations comprising a drug as listed herein (or a pharmaceutically acceptable salt of the medicament) may include one or more other active ingredients, or may be the only active ingredient present.
Furthermore, all terms used in the claims are to be interpreted according to their ordinary meaning in the technical field, unless explicitly defined otherwise herein. All references to "a/an/the element, apparatus, component, means, etc.” are to be interpreted openly as referring to at least one instance of the element, apparatus, component, means, etc., unless explicitly stated otherwise.
BRIEF DESCRIPTION OF THE DRAWINGS
Embodiments of the inventive concept will now be described, by way of example only, with reference to the accompanying drawings, in which:
Fig. 1 schematically shows a perspective view of a medicament cassette unit comprising a sub-assembly of the invention.
Fig. 2 schematically shows a medicament delivery device formed by a drive unit and the medicament cassette unit of Fig. 1 .
Fig. 3 schematically shows a perspective view of components of the sub-assembly of Fig. 1 .
Fig. 4 schematically shows a perspective view of a housing and a delivery member cover of the sub-assembly of Fig. 1 .
Fig. 5 schematically shows a perspective view of a rear end of the housing and the delivery member cover of Fig. 4.
Fig. 6 schematically shows a perspective view of a cap of the sub-assembly of the invention of Fig. 1 .
Fig. 7 schematically shows a perspective view of the cap of Fig. 6 and a proximal end of the delivery member cover of Fig. 4.
Fig. 8 schematically shows a perspective view of the housing of Fig. 4.
Figs 9-10 schematically show cross-section views of a proximal end of the sub-assembly.
Figs 11-12 schematically show perspective views of a lockout structure between the delivery member cover of the sub-assembly of Fig. 1 and the housing of the sub-assembly of Fig. 1 .
Figs 13-16 schematically show perspective views of a proximal end of the sub-assembly in another example.
Fig. 17 schematically shows a perspective view of a lock ring of the sub-assembly in another example and the delivery member cover of the sub-assembly in another example.
DETAILED DESCRIPTION
Figs 1-17 illustrate a sub-assembly of a medicament cassette unit. The term “medicament delivery device cassette unit” will sometimes be abbreviated as “cassette unit” in this description. It should be noted that both the term “medicament delivery device cassette unit” and the term “cassette unit” are used with the same meaning in this description.
The cassette unit is usually used with a medicament delivery device with two detachable parts, as shown in Fig. 2. There can be certain technical demands for making a medicament delivery device, such as a controllable medicament delivery speed; a high output force to deliver a high volume and/or high viscosity medicament; multiple indications for different medicament delivery stages; and/or data recording and/or communication, for example, to track prescription adherence. However, the cost of manufacturing medicament delivery devices that can perform all functions and fulfil the technical demands described above is typically high, which makes the use of such medicament delivery devices for frequent treatments less affordable. Medicament delivery devices with two detachable parts are usually made with a reusable part and a disposable part. The reusable part comprises most of the mechanical and/or electronic components. For example, the reusable part normally comprises a powerpack, namely, an assembly that comprises a power source and components that are configured to transfer the output force from the power source to a medicament. The disposable part is usually without electronics to lower the cost of manufacture. The disposable part, commonly referred to as a cassette unit C, is usually designed to accommodate a medicament container, e.g. a syringe or cartridge, that has a medicament contained within. The syringe or cartridge can be made of glass or plastic. The syringe or cartridge may comprise a rubber stopper sealing a distal end of the syringe or cartridge, and a septum or medicament delivery member with a rubber sheath sealing a
proximal end of the syringe or cartridge. Alternatively, the syringe or cartridge may be collapsible with only a septum or medicament delivery member (i.e. no stopper) with a rubber delivery member sheath sealing a proximal end of the syringe or cartridge. It should be noted that the septum or the rubber sheath usually provides a sterile seal for the medicament container of the cassette unit. The sterile seal is configured to be broken right when a user wants to carry out a medicament delivery operation.
The reusable part of the medicament delivery device, (i.e., a drive unit D), usually comprises a driver for expelling the medicament contained within the medicament container in the proximal direction of the medicament delivery device. The drive unit D may comprise a plunger rod for pushing on the medicament container. In one example, the stopper of the medicament container can therefore be moved in the proximal direction relative to the rest of the medicament container. In another example, the plunger rod may collapse the medicament container by pushing the medicament container in the proximal direction relative to the cassette unit C. The drive unit D also comprises a power source, such as a spring, a gas canister, or a motor-driven gear set, for providing the power required to expel the medicament. The focus of the concept described herein is a sub-assembly for the medicament delivery device cassette, not the drive unit, and various types of drive units could be used with the cassette units with the sub-assembly described herein. As such, the drive unit will not be comprehensively described.
The sub-assembly of the invention provides a safety mechanism configured to prevent the user from breaking the sterile seal of the medicament container of the cassette unit before attaching the cassette unit to the drive unit. The sub-assembly also provides a mechanism that a delivery member cover is moved in a proximal direction relative to the tubular body when the cassette unit is attached to the drive unit D (the cassette unit comprises the subassembly of the invention). The proximal movement of the delivery member cover is configured to unlock the safety mechanism.
The sub-assembly comprises a tubular housing 1 ; T, a cap 2; 2’, and a delivery member cover 3; 3’. The tubular housing 1 ; T extends along a longitudinal axis L between a proximal end and a distal end.
The tubular housing 1 ; T is configured to receive the medicament container of the cassette unit. The tubular housing 1 ; T comprises a housing body 10; 10’ and a distal lid 13. In a preferred example, the medicament container is configured to be inserted into the housing body 10 through the distal end of the housing body 10. The step of inserting the medicament container into the housing body 10 can be carried out during the assembly step in a medicament delivery device manufacture site, or by a caregiver, e.g., a pharmacist or a nurse. After the medicament container is inserted into the housing body 10, the distal lid 13
is configured to attach to the distal end of the housing body 10, so that the medicament container will not fall from the distal end of the housing 1 . An aperture is arranged in the distal lid 13, so that a plunger rod from the drive unit can move into the housing 1 for expelling the medicament within the medicament container.
In a preferred example, the tubular housing 1 comprises a fastener 11 configured to engage with a counter fastener DO of the drive unit D, so that the cassette unit is attached to the drive unit. In a preferred example, the fastener 11 is on the distal end of the housing 1 . The fastener 11 and the counter fastener DO can form a bayonet engagement, a screw thread engagement, or a snap-fit engagement, dependent on the design of the medicament delivery device, as shown in Fig. 2. Alternatively, the sub-assembly comprises a lock ring 5 attached to the housing 1’. The lock ring 5 is axially immovable and rotatable around the longitudinal axis L relative to the housing T. In this example, the lock ring 5 comprises a fastener 51 configured to be engaged with the counter fastener DO of the drive unit, as shown in Fig. 17. In a preferred example, the fastener 51 and the counter fastener DO formed a bayonet connection.
In a preferred example, a window 12 is arranged in the wall of the housing body 10, so that the user can observe the medicament through the window 12.
The delivery member cover 3; 3’ comprises a tubular section 30; 30’ is arranged telescopically relative to the proximal end of the housing 1 ; T. The tubular section 30; 30’ of the delivery member cover 3; 3’ is configured to cover the medicament delivery member of the cassette unit, e.g., an injection needle. In a preferred example, the delivery member cover 3; 3’ comprises an arm 31 ; 3T extending from the tubular section 30; 30’ towards the distal end of the housing 1 ; T.
In a preferred example, the delivery member cover 3 comprises a flexible section 32 at a distal end of the delivery member cover 3. Preferably, the flexible section is a part of the arm or is extending from the arm 31 . The flexible section comprises a protrusion 32 extending from the delivery member cover 3 towards the tubular housing 1 in the direction transverse to the longitudinal axis L, as shown in Fig. 4.
Furthermore, in a preferred example, the delivery member cover 3 comprises a lockout structure 33, as shown in Fig. 4 and Fig. 11 . The delivery member cover 3 is configured to be moved in the distal direction by the user such that the medicament delivery member of the cassette unit is exposed and thus the medicament delivery operation can be carried out. When the medicament delivery operation is completed, the user can lift the delivery member cover 3 from a medicament delivery site, the delivery member cover 3 can move in the proximal direction relative to the housing 1 to cover the medicament delivery member again.
The lockout structure 33 is configured to block the delivery member cover 3 from moving in the distal direction relative to the housing 1 after the user lift the delivery member cover 3 from the medicament delivery site so that the used medicament delivery member will be covered and prevented from being accessible from the outside of the medicament delivery device, as shown in Fig. 12. In a preferred example, the lockout structure 33 comprises a track 33a and the housing 1 comprises a track follower 15, e.g., a protrusion, configured to move along the track. A locking ton gue 33b extends from a portion of the track 33a that the track follow can move into that portion after the delivery member cover 3 covers the medicament delivery member again. In one example, the delivery member cover 3 is configured to be moved to cover the medicament delivery member by a biasing member 4. In this example, the locking tongue 33b can be designed to be bent and disengaged from the track follower 15 of the housing when the force that applies to the delivery member cover 3 in the distal direction is greater than a predetermined magnitude. Therefore, the locking tongue 33b can be prevented from being damaged by being squeezed between the delivery member cover 3 and the track follower 15. After the force applies to the delivery member cover 3 in the distal direction is removed or becomes weaker than the force from the biasing member 4, the biasing member will move the delivery member cover 3 back to the position that the delivery member is covered and the locking tongue 3b will engage the track follower 15 again to lock the delivery member cover 3 from being moved in the distal position. This design is configured to prevent a damage to the lockout structure; in particular, when the used medicament delivery device falls. As the damage of the lockout structure might result in that the delivery member cover will not be locked after the medicament delivery device is used, thus might result in an accidental injury to people by a used medicament delivery member. In one example, the locking tongue 33b comprises a lever 33c configured to guide the locking tongue to disengaged from the track follower 15. For example, the locking tongue 33b comprises a distally directed surface 33d configured to engage with the track follower 15 of the housing. In this example, the lever 33c extends beyond the distally directed surface 33d of the locking tongue 33b, as shown in Fig. 11 . In this example, the track follower 15 is configured to press the lever 33c in the direction transverse to the longitudinal axis L, and towards the longitudinal axis when the track follower 15 is engaged with the distally directed surface 33d of the locking tongue 33b. Therefore, when the force that applies to the delivery member cover 3 in the distal direction is greater than the predetermined magnitude and the distally directed surface 33d is engaged with the track follower 15, the lever will be pressed further towards the longitudinal axis L and thus pulls the locking tongue towards the longitudinal axis L to disengage from the track follower 15.
The cap 2; 2’ is releasably attached to the tubular section 30; 30’ of the delivery member cover 3; 3’. The cap 2; 2’ operably connects to the sterile seal of the medicament container of the cassette unit, so that when the cap 2; 2’ is removed the sterile seal of the medicament
container of the cassette unit is broken. The cap 2; 2’ comprises a user-accessible section 20; 20’, so that the user can grip on the user-accessible section 20; 20’ to remove the cap 2; 2’ from the delivery member cover 3; 3’. In a preferred example, the cap 2 comprises a gripping arm 22 extending towards the distal end of the tubular housing 1 . The gripping arm 22 comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
The delivery member cover 3; 3’ is configured to lock the cap 2; 2’ to the housing 1 ; T. The delivery member cover 3; 3’ is movable between a first position where the cap 2; 2’ is locked to the housing 1 ; 1 ’ by the delivery member cover 3; 3’ such that the user cannot remove the cap 2; 2’ from the housing 1 ; T and a second position where the cap 2; 2’ is no longer locked to the housing 1 ; 1 ’ by the delivery member cover 3; 3’. The delivery member cover 3; 3’ comprises a the distally directed surface 31a; 31a’ and the cap 2; 2’ comprises a proximally directed surface 21 a; 21 a’. When the delivery member cover 3; 3’ is in the first position, the distally directed surface 31a; 31a’ of the delivery member cover 3; 3’ is adjacent to the proximally directed surface 21a; 21a’ of the cap 2; 2’, as shown in Fig. 9 and Fig. 16. When the delivery member cover 3; 3’ is in the second position, the distally directed surface 31 a; 31 a’ of the delivery member cover 3; 3’ is away from the proximally directed surface 21a; 21a’ of the cap 2; 2’ such that the cap 2; 2’ can be removed from the delivery member cover 3; 3’ by being moved in the proximal direction relative to the delivery member cover 3; 3’, as shown in Fig. 10.
In one example, the delivery member cover 3 is movable in the direction of the longitudinal axis L relative to the housing 1 between a distal position (shown in Fig. 9) and a proximal position (shown in Fig. 10). The safety mechanism is provided that the cap 2 cannot be detached from the tubular section 30 of the delivery member cover 3 when the delivery member cover 3 is in the distal position such that the delivery member cover is in the first position, and can be detached from the tubular section 30 of the delivery member cover 3 when the delivery member cover moves a distance X into the in the proximal direction relative to the housing 1 into the proximal position such that the delivery member cover is moved to the second position.
The delivery member cover comprises the distally directed surface 31a and the cap comprises the proximally directed surface 21a adjacent to the distally directed surface 31a of the delivery member cover 3. At least one of the distally directed surface and the proximally directed surface is a chamfered surface bevelled relative to the longitudinal axis L. In the preferred example as shown in Fig. 7, the proximally directed surface 21 a is a chamfered surface bevelled relative to the longitudinal axis L. Preferably, the bevelled angle can be 30- 70 degrees, more preferred angle can be 40-60 degrees. In a preferred example, the proximally directed surface 21 a is formed on a protrusion that extends from an inner surface
of a flexible wall 21 of the cap 2 in the direction transverse to the longitudinal axis L. Alternatively, the distally directed surface can be formed on a protrusion that extends from a flexible wall of the delivery member cover. In a preferred example, the flexible wall 21 of the cap 2 is a flexible arm 21 extending from the user-accessible section in the direction of the longitudinal axis L towards the distal end of the housing 1. In a preferred example, the protrusion is arranged at the distal end of the flexible arm 21 .
In one example where the cap 2 comprises the gripping arm 22, the gripping arm 22 of the cap 2 is arranged within the delivery member cover 3, and the flexible arm 21 of the cap 2 is arranged between the tubular housing 1 and the delivery member cover 3, as shown in Figs 9-10.
The housing 1 comprises a support surface 10a defined by an inner surface of a wall of the housing body 10. The support surface 10a is closer to the proximal end of the housing 1 than the distal end of the housing 1 . The support surface 10a is arranged next to a proximal inner surface 10b of the housing body 10. In a preferred example, the support surface 10a is closer to the distal end of the housing 1 than the proximal inner surface 10b. In a preferred example, the support surface 10a is closer to the longitudinal axis than the proximal inner surface 10b of the housing body 10 as shown in Figs 8-10. In a preferred example, the housing 1 comprises two support surfaces 10a and two proximal inner surfaces 10b. The two support surfaces 10a defines a first transverse distance. The first transverse distance is shorter than a second transverse distance between the two proximal inner surfaces 10b.
The cap 2 is engaged with the delivery member cover 3 via the engagement between the proximally directed surface 21 a and the distally directed surface 31 a, so that the cap 2 moves with the delivery member cover 3 from the distal position to the proximal position.
When the delivery member cover 3 is in the distal position, the support surface 10a of the tubular housing 1 is aligned with an outer surface of the flexible wall 21 in the direction transverse to the longitudinal axis L, as shown in Fig. 9. When the delivery member cover 3 is in the proximal position, the support surface 10a of the tubular housing 1 is closer to the distal end of the housing 1 than the flexible wall 21 , as shown in Fig. 10. As a result, when the delivery member cover 3 is in the distal position, the flexible wall 21 is blocked from moving in the direction transverse to the longitudinal axis L by the support surface 10a, and when the delivery member cover 3 is in the proximal position, the flexible wall 21 is no longer blocked from moving in the direction transverse to the longitudinal axis L by the support surface 10a. Therefore, if the user pulls the cap 2 in the proximal position when the delivery member cover 3, the bevelled proximally directed surface 21 will divide the axial pulling force to deflect the flexible wall 21 , thereby moving the flexible wall in the direction transverse to the longitudinal axis L. When the flexible wall 21 moves in the direction transverse to the
longitudinal axis L, the proximally directed surface 21a of the cap 2 is offset from the distally directed surface 31a of the delivery member cover 3, so that the cap 2 can be removed from the delivery member cover 3 as the proximally directed surface 21 a of the cap 2 is no longer engaged with the distally directed surface 31a of the delivery member cover 3.
It should be noted that, the proximal inner surface 10b of the housing 1 is dimensioned wider enough to allow the proximally directed surface 21 of the cap 2 can disengage with the distally directed surface 31a of the delivery member cover 3. The exact dimension is of the proximal inner surface 10b of the housing 1 is dependent on the design. Alternatively, instead of the proximal inner surface, an elongated cut-out can be arranged in the proximal end of the housing body. The elongated cut-out is arranged next to the support surface and is close to the proximal end of the housing than the support surface.
In a preferred example, the sub-assembly comprises the biasing member 4 extending along the longitudinal axis L between a proximal end and a distal end. The distal end of the biasing member 4 is adjacent to a proximally directed surface of the tubular housing 1 and the proximal end of the biasing member 4 is adjacent to a distally directed surface of the delivery member cover 3. The biasing member 4 is configured to move the delivery member cover 3 from the distal position to the proximal position.
In a preferred example, the sub-assembly comprises an initial lock mechanism, so that the delivery member cover 3 is locked from moving to the proximal position until the cassette unit that comprises the sub-assembly is attached to the drive unit D. In one example, the initial lock arrangement comprises the flexible section at the distal end of the delivery member cover 3.
In a preferred example, a cut-out 14 is arranged in a wall of the tubular housing 1 . The flexible section is movable in the direction transverse to the longitudinal axis L relative to the delivery member cover 3 between an engaged position where the protrusion 32 of the flexible section is positioned within the cut-out 14 of the tubular housing 1 and a released position where the protrusion 32 of the flexible section is positioned out of the cut-out 14 the tubular housing 1 . It should be noted that, the cut-out can be replaced by a recess.
In a preferred example, the flexible section of the delivery member cover 3 is moved from the engaged position to the released position when the protrusion 32 of the flexible section is pressed from the outside of the tubular housing 1 . The flexible section of the delivery member cover 3 is configured to be moved from the engaged position to the released position by a section of the drive unit D of the medicament delivery device when the cassette unit with the sub-assembly is attached to the drive unit. Preferably, the flexible section is
moved by the drive unit via the protrusion 32. In this example, the protrusion 32 is configured to extend out from the housing 1 through the cut-out 14 of the housing 1 , as shown in Fig. 5.
When the cassette unit is inserted into the drive unit D, the section of the drive unit D, e.g. an inner surface of the drive unit moves the protrusion 32 in the direction transverse to the longitudinal axis L, thereby deforming the flexible section. The deformation of the flexible section causes the protrusion 32 to move out from the cut-out 14 of the housing 1 , so that the housing 1 is not locked to the delivery member cover 3. As a result, the delivery member cover 3 is moved from the distal position to the proximal position by the biasing member 4.
In another example, the delivery member cover 3’ is configured to be rotated around the longitudinal axis L relative to the housing T from the first position to the second position. In this example, the distally directed surface 31 a’ of the delivery member cover 3’ can be provided by a ledge 3T arranged on an inner surface of the tubular section 30’, as shown in Figs. 14-15. A groove 31 b’ is arranged in the ledge 3T, as shown in Fig. 14. The proximally directed surface 21 a’ of the cap 2’ can be arranged at an elongated rib 2T of the cap 2’. Thus, when the delivery member cover 3’ is in the first position, as shown in Fig. 15, the distally directed surface 31 a’ of the delivery member cover 3’ is adjacent to the proximally directed surface 21 a’ of the cap 2’; therefore, the cap 2’ cannot be removed from the housing 1 ’. When the delivery member cover 3’ is rotated to the second position, the distally directed surface 31 a’ of the delivery member cover 3’ is no longer adjacent to the proximally directed surface 21 a’ of the cap 2’; instead, the the proximally directed surface 21 a’ of the cap 2’ is lined up with the groove 31 b’; therefore, the cap 2’ can be removed from the housing 1 ’ by being moved in the proximal direction relative to the housing T and the delivery member cover 3’. In a preferred example, a proximally directed recess 16’ is arranged in a wall of the housing T, as shown in Fig. 16. One end of the elongated rib 2T of the cap 2’ is positioned within the recess 16’ such that the cap 2’ cannot be rotated relative to the housing 1 ’.
In one example where the sub-assembly comprises the lock ring 5, the lock ring 5 comprises a rotational surface 52 facing in the direction transverse to the longitudinal axis L. The delivery member cover 3’ comprises a counter rotational surface adjacent to the rotational surface 52 of the lock ring 5 such that the delivery member cover is configured to be rotated from the first position to the second position by a rotation of the lock ring 5, as shown in Fig. 17. In a preferred example, the counter rotational surface of the delivery member cover 3’ is a transverse edge of the arm 3T of the delivery member cover 3’. In one example where the lock ring 5 comprises the fastener 51 configured to be engaged with a counter fasten er DO of the drive unit and the fastener 51 and the counter fastener DO formed a bayonet connection, as the lock ring is rotatable relative to the housing T, when the user twist the housing T relative to the drive unit for connecting the cassette unit to the drive unit via the bayonet
connection, the lock ring 5 rotates the delivery member cover 3’ from the first position to the second position.
The inventive concept has mainly been described above with reference to a few examples. However, as is readily appreciated by a person skilled in the art, other embodiments than the ones disclosed above are equally possible within the scope of the inventive concept, as defined by the appended claims.
Some aspects of the invention are defined by the below clauses.
1 . A sub-assembly of a medicament cassette unit, the sub-assembly comprising: a tubular housing, a cap, and a delivery member cover; wherein the tubular housing extends along a longitudinal axis between a proximal end and a distal end; wherein the tubular housing is configured to receive a medicament container; wherein the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; wherein the delivery member cover comprises a distally directed surface; wherein the cap is releasably attached to the tubular section of the delivery member cover; wherein the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover; wherein at least one of the distally directed surface and the proximally directed surface is a chamfered surface bevelled relative to the longitudinal axis; wherein the distally directed surface is formed on a protrusion that extends from an inner surface of a flexible wall of the delivery member cover in a direction transverse to the longitudinal axis or the proximally directed surface is formed on a protrusion that extends from an inner surface of a flexible wall of the cap in the direction transverse to the longitudinal axis; and wherein the delivery member cover is axially movable relative to the tubular housing from a distal position where a support surface of the tubular housing is aligned with an outer surface of the flexible wall in the direction transverse to the longitudinal axis and a proximal position where the support surface of the tubular housing is closer to the distal end of the housing than the flexible wall.
2. The sub-assembly according to clause 1 , wherein the flexible wall is defined by a flexible arm extending in the direction of the longitudinal axis.
3. The sub-assembly according to clause 2, wherein the cap comprises the flexible arm extending towards the distal end of the housing.
4. The sub-assembly according to any one of the preceding clauses, wherein the distally directed surface of the delivery member cover extends from an outer surface of the tubular section of the delivery member cover.
5. The sub-assembly according to any one of the preceding clauses, the sub-assembly comprising a biasing member extending along the longitudinal axis between a proximal end and a distal end; and wherein the distal end of the biasing member is adjacent to a proximally directed surface of the tubular housing and the proximal end of the biasing member is adjacent to a distally directed surface of the delivery member cover.
6. The sub-assembly according to any one of the preceding clauses, wherein the delivery member cover comprises a ledge extending in the direction transverse to the longitudinal axis; and wherein the distally directed surface of the delivery member cover is defined by the ledge.
7. The sub-assembly according to any one of the preceding clauses, wherein the cap comprises a gripping arm extending towards the distal end of the tubular housing; wherein the gripping arm comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
8. The sub-assembly according to clause 7 when dependent on clause 2 or 3, wherein the gripping arm of the cap is arranged within the delivery member cover; and wherein the flexible wall of the cap is arranged between the tubular housing and the delivery member cover.
9. The sub-assembly according to any one of the preceding clauses, wherein the delivery member cover comprises a flexible section at a distal end of the delivery member cover; and wherein the flexible section comprises a protrusion extending from the delivery member cover towards the tubular housing in the direction transverse to the longitudinal axis.
10. The sub-assembly according to clause 9, wherein a cut-out or recess is arranged in a wall of the tubular housing; and wherein the flexible section is movable in the direction transverse to the longitudinal axis relative to the delivery member cover between an engaged position where the protrusion of the flexible section is positioned within the cut-out or recess of the tubular housing and a released position where the protrusion of the flexible section is positioned out of the cut-out or recess of the tubular housing.
11. The sub-assembly according to clause 10, wherein the flexible section of the delivery member cover is moved from the engaged position where the protrusion of the flexible section is positioned within the cut-out to the released position where the protrusion of the flexible section is positioned out of the cut-out when the protrusion of the flexible section is pressed from the outside of the tubular housing.
12. The sub-assembly according to clause 11 , wherein the flexible section of the delivery member cover is configured to be moved from the engaged position to the released position by a section of a drive unit of the medicament delivery device when the cassette unit with the sub-assembly is attached to the drive unit.
13. The sub-assembly according to clause 12, wherein the flexible section is moved by the drive unit via the protrusion.
14. The sub-assembly according to any one of clauses 10-13, wherein the protrusion is configured to extend out from the housing through the cut-out of the housing.
15. A method of operating a medicament delivery device, the method comprising the following steps in the following order: providing a medicament cassette unit of the medicament delivery device, wherein the medicament cassette unit comprises the sub-assembly according to clause 14; providing a drive unit of the medicament delivery device, wherein the drive unit comprises a section for receiving a part of the medicament cassette unit; inserting the part of the medicament cassette unit into the section of the drive unit, thereby engaging the flexible section of the delivery member cover of the medicament cassette unit with an inner surface of the drive unit; moving the delivery member cover from the distal position to the proximal position; and pulling the cap in the proximal direction relative to the tubular housing, thereby removing the cap from the tubular housing.
16. A sub-assembly of a medicament cassette unit, the sub-assembly comprising: a tubular housing, a cap, and a delivery member cover; wherein the tubular housing extends along a longitudinal axis between a proximal end and a distal end; wherein the tubular housing is configured to receive a medicament container; wherein the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; wherein the delivery member cover comprises a distally directed surface; wherein the cap is releasably attached to the tubular section of the delivery member cover; wherein the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover; and wherein the delivery member cover is movable between a first position where the distally directed surface of the delivery member cover is adjacent to the proximally directed surface of the cap and a second position where the distally directed surface of the delivery member cover is away from the proximally directed surface of the cap such that the cap can be removed from the delivery member cover by being moved in the proximal direction relative to the delivery member cover.
17. The sub-assembly according to clause 16, wherein at least one of the distally directed surface and the proximally directed surface is a chamfered surface bevelled relative to the longitudinal axis; wherein the distally directed surface is formed on a protrusion that extends from an inner surface of a flexible wall of the delivery member cover in a direction transverse to the longitudinal axis or the proximally directed surface is formed on a protrusion that extends from an inner surface of a flexible wall of the cap in the direction transverse to the longitudinal axis; and wherein the delivery member cover is axially movable relative to the tubular housing from a distal position where a support surface of the tubular housing is aligned with an outer surface of the flexible wall in the direction transverse to the longitudinal axis such that the delivery member cover is in the first position and a proximal position where the support surface of the tubular housing is closer to the distal end of the housing than the flexible wall such that the delivery member cover is in the second position.
18. The sub-assembly according to clause 17, wherein the flexible wall is defined by a flexible arm extending in the direction of the longitudinal axis.
19. The sub-assembly according to clause 18, wherein the cap comprises the flexible arm extending towards the distal end of the housing.
20. The sub-assembly according to any one of clauses 16-19, wherein the distally directed surface of the delivery member cover extends from an outer surface of the tubular section of the delivery member cover.
21. The sub-assembly according to any one of clauses 16-20, the sub-assembly comprising a biasing member extending along the longitudinal axis between a proximal end and a distal end; and wherein the distal end of the biasing member is adjacent to a proximally directed surface of the tubular housing and the proximal end of the biasing member is adjacent to a distally directed surface of the delivery member cover.
22. The sub-assembly according to any one of clauses 16-21 , wherein the delivery member cover comprises a ledge extending in the direction transverse to the longitudinal axis; and wherein the distally directed surface of the delivery member cover is defined by the ledge.
23. The sub-assembly according to any one of clauses 16-22, wherein the cap comprises a gripping arm extending towards the distal end of the tubular housing; wherein the gripping arm comprises a proximally directed surface configured to engage with a delivery member sheath of a medicament container.
24. The sub-assembly according to clause 23 when dependent on clause 18 or 19, wherein the gripping arm of the cap is arranged within the delivery member cover; and wherein the flexible wall of the cap is arranged between the tubular housing and the delivery member cover.
The sub-assembly according to any one of clauses 16-24, wherein the delivery member cover comprises a flexible section at a distal end of the delivery member cover; and wherein the flexible section comprises a protrusion extending from the delivery member cover towards the tubular housing in the direction transverse to the longitudinal axis. The sub-assembly according to clause 25, wherein a cut-out or recess is arranged in a wall of the tubular housing; and wherein the flexible section is movable in the direction transverse to the longitudinal axis relative to the delivery member cover between an engaged position where the protrusion of the flexible section is positioned within the cut-out or recess of the tubular housing and a released position where the protrusion of the flexible section is positioned out of the cut-out or recess of the tubular housing. The sub-assembly according to clause 26, wherein the flexible section of the delivery member cover is moved from the engaged position where the protrusion of the flexible section is positioned within the cut-out to the released position where the protrusion of the flexible section is positioned out of the cut-out when the protrusion of the flexible section is pressed from the outside of the tubular housing. The sub-assembly according to clause 27, wherein the flexible section of the delivery member cover is configured to be moved from the engaged position to the released position by a section of a drive unit of the medicament delivery device when the cassette unit with the sub-assembly is attached to the drive unit. The sub-assembly according to clause 28, wherein the flexible section is moved by the drive unit via the protrusion. The sub-assembly according to any one of clauses 26-29, wherein the protrusion is configured to extend out from the housing through the cut-out of the housing. The sub-assembly according to clause 16, wherein the sub-assembly comprises a lock ring attached to the housing; wherein the lock ring is axially immovable and rotatable around the longitudinal axis relative to the housing; wherein the lock ring comprises a rotational surface facing in the direction transverse to the longitudinal axis; wherein the delivery member cover comprises a counter rotational surface adjacent to the rotational surface of the lock ring such that the delivery member cover is configured to be rotated from the first position to the second position by a rotation of the lock ring. The sub-assembly according to clause 31 , wherein the lock ring comprises a fastener configured to be engaged with a counter fastener of the drive unit; and wherein the fastener and the counter fastener formed a bayonet connection.
Claims
1 . A sub-assembly of a medicament cassette unit, the sub-assembly comprising: a tubular housing, a cap, and a delivery member cover; wherein the tubular housing extends along a longitudinal axis between a proximal end and a distal end; wherein the tubular housing is configured to receive a medicament container; wherein the delivery member cover comprises a tubular section arranged telescopically relative to the proximal end of the tubular housing; wherein the delivery member cover comprises a distally directed surface; wherein the cap is releasably attached to the tubular section of the delivery member cover; wherein the cap comprises a proximally directed surface adjacent to the distally directed surface of the delivery member cover; and wherein the delivery member cover is movable between a first position where the distally directed surface of the delivery member cover is adjacent to the proximally directed surface of the cap and a second position where the distally directed surface of the delivery member cover is away from the proximally directed surface of the cap such that the cap can be removed from the delivery member cover by being moved in the proximal direction relative to the delivery member cover.
2. The sub-assembly according to claim 1 , wherein at least one of the distally directed surface and the proximally directed surface is a chamfered surface bevelled relative to the longitudinal axis; wherein the distally directed surface is formed on a protrusion that extends from an inner surface of a flexible wall of the delivery member cover in a direction transverse to the longitudinal axis or the proximally directed surface is formed on a protrusion that extends from an inner surface of a flexible wall of the cap in the direction transverse to the longitudinal axis; and wherein the delivery member cover is axially movable relative to the tubular housing from a distal position where a support surface of the tubular housing is aligned with an outer surface of the flexible wall in the direction transverse to the longitudinal axis such that the delivery member cover is in the first position and a proximal position where the support surface of the tubular housing is closer to the distal end of the housing than the flexible wall such that the delivery member cover is in the second position.
3. The sub-assembly according to claim 2, wherein the flexible wall is defined by a flexible arm extending in the direction of the longitudinal axis.
4. The sub-assembly according to claim 3, wherein the cap comprises the flexible arm extending towards the distal end of the housing.
5. The sub-assembly according to any one of the preceding claims, wherein the distally directed surface of the delivery member cover extends from an outer surface of the tubular section of the delivery member cover.
6. The sub-assembly according to any one of the preceding claims, the sub-assembly comprising a biasing member extending along the longitudinal axis between a proximal end and a distal end; and wherein the distal end of the biasing member is adjacent to a proximally directed surface of the tubular housing and the proximal end of the biasing member is adjacent to a distally directed surface of the delivery member cover.
7. The sub-assembly according to any one of the preceding claims, wherein the delivery member cover comprises a ledge extending in the direction transverse to the longitudinal axis; and wherein the distally directed surface of the delivery member cover is defined by the ledge.
8. The sub-assembly according to any one of the preceding claims, wherein the delivery member cover comprises a flexible section at a distal end of the delivery member cover; and wherein the flexible section comprises a protrusion extending from the delivery member cover towards the tubular housing in the direction transverse to the longitudinal axis.
9. The sub-assembly according to claim 8, wherein a cut-out or recess is arranged in a wall of the tubular housing; and wherein the flexible section is movable in the direction transverse to the longitudinal axis relative to the delivery member cover between an engaged position where the protrusion of the flexible section is positioned within the cut-out or recess of the tubular housing and a released position where the protrusion of the flexible section is positioned out of the cut-out or recess of the tubular housing.
10. The sub-assembly according to claim 9, wherein the flexible section of the delivery member cover is moved from the engaged position where the protrusion of the flexible section is positioned within the cut-out to the released position where the protrusion of the flexible section is positioned out of the cut-out when the protrusion of the flexible section is pressed from the outside of the tubular housing.
The sub-assembly according to claim 10, wherein the flexible section of the delivery member cover is configured to be moved from the engaged position to the released position by a section of a drive unit of the medicament delivery device when the cassette unit with the sub-assembly is attached to the drive unit. The sub-assembly according to claim 11 , wherein the flexible section is moved by the drive unit via the protrusion. The sub-assembly according to any one of claims 9-12, wherein the protrusion is configured to extend out from the housing through the cut-out of the housing. The sub-assembly according to claim 1 , wherein the sub-assembly comprises a lock ring attached to the housing; wherein the lock ring is axially immovable and rotatable around the longitudinal axis relative to the housing; wherein the lock ring comprises a rotational surface facing in the direction transverse to the longitudinal axis; wherein the delivery member cover comprises a counter rotational surface adjacent to the rotational surface of the lock ring such that the delivery member cover is configured to be rotated from the first position to the second position by a rotation of the lock ring. The sub-assembly according to claim 14, wherein the lock ring comprises a fastener configured to be engaged with a counter fastener of the drive unit; and wherein the fastener and the counter fastener formed a bayonet connection.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22150025 | 2022-01-03 | ||
EP22150025.9 | 2022-01-03 | ||
US202263419561P | 2022-10-26 | 2022-10-26 | |
US63/419,561 | 2022-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023126249A1 true WO2023126249A1 (en) | 2023-07-06 |
Family
ID=84943674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/086956 WO2023126249A1 (en) | 2022-01-03 | 2022-12-20 | A sub-assembly of a medicament cassette unit |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023126249A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843036A (en) * | 1996-08-23 | 1998-12-01 | Becton Dickinson And Company | Non-dosing cartridge for an injection device |
US20150182691A1 (en) * | 2012-07-30 | 2015-07-02 | Ucb Biopharma Sprl | Auto-injector |
US20190001065A1 (en) * | 2015-08-19 | 2019-01-03 | Carebay Europe Ltd | Variable single dose medicament delivery device |
-
2022
- 2022-12-20 WO PCT/EP2022/086956 patent/WO2023126249A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843036A (en) * | 1996-08-23 | 1998-12-01 | Becton Dickinson And Company | Non-dosing cartridge for an injection device |
US20150182691A1 (en) * | 2012-07-30 | 2015-07-02 | Ucb Biopharma Sprl | Auto-injector |
US20190001065A1 (en) * | 2015-08-19 | 2019-01-03 | Carebay Europe Ltd | Variable single dose medicament delivery device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110325233B (en) | Safety syringe | |
EP2654835B1 (en) | Auto-injector | |
US9731081B2 (en) | Contact trigger release needle guard with elastic spring | |
EP2467183B1 (en) | Patient-contact activated needle stick safety device | |
US10661020B2 (en) | Medication delivery device | |
US20170239424A1 (en) | Automatic Injection Device With Variable Dosing | |
WO2023126249A1 (en) | A sub-assembly of a medicament cassette unit | |
US11679206B2 (en) | Semi-reusable palm activated injector system | |
JP2022551163A (en) | Keyed connector for drug delivery device | |
US20240335620A1 (en) | A cassette sub-assembly for a cassette unit | |
WO2023194132A1 (en) | A sub-assembly of a medicament delivery device | |
WO2023247179A1 (en) | A sub-assembly of a medicament delivery device | |
WO2023202885A1 (en) | A sub-assembly of a medicament delivery device | |
EP3834867B1 (en) | Drive mechanism | |
EP4448051A1 (en) | A sub-assembly of a medicament delivery device | |
WO2023061770A1 (en) | A sub-assembly of a medicament delivery device cassette unit and a method of operating a medicament delivery device cassette unit comprising the sub-assembly | |
EP4448052A1 (en) | Sub-assembly of a medicament delivery device | |
WO2024008491A1 (en) | A sub-assembly of a medicament delivery device | |
WO2023151956A1 (en) | A tubular needle cover of a pen needle assembly | |
CN118284448A (en) | Cartridge subassembly for cartridge unit | |
CN118922220A (en) | Subassembly of a medicament delivery device | |
WO2019204858A1 (en) | Prefillable safety syringe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22843173 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022843173 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022843173 Country of ref document: EP Effective date: 20240805 |